FLOX-0-ZOLE TAB by Dr Precision is a high-efficacy dual-therapy antibiotic tablet combining Ofloxacin 200 mg and Metronidazole 400 mg in a fixed-dose formulation. Specifically designed for addressing mixed bacterial and protozoal infections, this potent combination targets infections predominantly in the gastrointestinal and genitourinary systems, including amoebic dysentery, giardiasis, pelvic inflammatory disease, bacterial vaginosis, and various post-surgical and dental infections. Manufactured by BluepillExpress under WHO-GMP certification, FLOX-0-ZOLE TAB stands out for its robust antimicrobial synergy, effectively combating both aerobic and anaerobic pathogens. Its unique mechanism leverages the fluoroquinolone activity of Ofloxacin and the nitroimidazole action of Metronidazole to disrupt DNA processes essential to pathogens, ensuring rapid and comprehensive infection control. This product is especially suited for pharmaceutical distributors, healthcare providers, and exporters targeting global markets demanding high-quality, regulatory-compliant antibiotics for complex infection management.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Ofloxacin 200 mg and Metronidazole 400 mg |
| Therapeutic Use | Effective for mixed bacterial and protozoal infections |
| Targeted Conditions | Gastrointestinal infections, genitourinary infections, pelvic inflammatory disease, dental and post-surgical infections |
| Mechanism of Action | Ofloxacin inhibits bacterial DNA gyrase/topoisomerase IV; Metronidazole disrupts DNA synthesis in anaerobic bacteria and protozoa |
| Manufacturing Standard | WHO-GMP certified |
| Manufacturer | BluepillExpress under Dr Precision label |
| Formulation Type | Fixed-dose tablet |
| Suitability | Ideal for global export and pharmaceutical distribution |
| Antimicrobial Spectrum | Effective against aerobic and anaerobic bacteria and protozoa |
| Regulatory Compliance | Manufactured under GMP-compliant quality standards |
| Attributes | Description |
|---|---|
| Dosage Form | Tablet |
| Dosage Strength | Ofloxacin 200 mg + Metronidazole 400 mg per tablet |
| Packaging | Available in export-ready packaging, customizable as per buyer requirement |
| Shelf Life | Typically 2 years (subject to specific batch and regulatory approvals) |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Pharmacological Class | Fluoroquinolone + Nitroimidazole antibiotic combination |
| Indications | Amoebic and bacterial dysentery, giardiasis, PID, bacterial vaginosis, infective diarrhea, dental infections, periodontal abscesses |
| Compliance | WHO-GMP certified manufacturing facility |
| Manufacturer | BluepillExpress |
| Labeling | Marketed under Dr Precision brand |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
FLOX-0-ZOLE TAB is best indicated for treating mixed bacterial and protozoal infections, including amoebic and bacterial dysentery, giardiasis, pelvic inflammatory disease, bacterial vaginosis, abdominal and post-surgical infections, infective and traveler's diarrhea, as well as dental infections and periodontal abscesses.
Ofloxacin targets aerobic bacteria by inhibiting DNA gyrase and topoisomerase IV enzymes critical for bacterial replication, while Metronidazole is activated under anaerobic conditions to disrupt DNA synthesis in anaerobic bacteria and protozoa. Their combined effect covers a broad spectrum of pathogens including both aerobic and anaerobic bacteria plus protozoal organisms, enabling effective treatment of complex mixed infections.
Yes, FLOX-0-ZOLE TAB is manufactured under WHO-GMP certification by BluepillExpress, adhering to international quality and regulatory standards, making it highly suitable for export and distribution in regulated global pharmaceutical markets.
FLOX-0-ZOLE TAB is produced in WHO-GMP certified facilities under the Dr Precision brand, ensuring stringent compliance with Good Manufacturing Practices, high-quality formulation precision, safety protocols, and quality assurance.
Yes, the Metronidazole component of FLOX-0-ZOLE TAB is highly effective against anaerobic bacteria commonly found in post-surgical infections, while Ofloxacin covers aerobic bacteria, making this tablet suitable for managing such mixed infections.
FLOX-0-ZOLE TAB is provided in export-ready, customizable packaging to meet buyer needs, with a typical shelf life of around 2 years, subject to regulatory compliance and batch-specific certifications.
Country Of Origin: India
FLOX-0-ZOLE TAB is a potent dual-therapy combination of Ofloxacin 200 mg and Metronidazole 400 mg, designed to effectively combat a wide range of bacterial and protozoal infections, particularly in the gastrointestinal and genitourinary systems. This fixed-dose combination ensures enhanced antimicrobial action, offering rapid relief from mixed infections. Manufactured under WHO-GMP certification by BluepillExpress, it is ideal for global markets seeking high-quality, export-ready formulations.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
FLOX-0-ZOLE TAB is a synergistic antimicrobial therapy that brings together the fluoroquinolone antibiotic Ofloxacin and the nitroimidazole antiprotozoal Metronidazole. The combination is highly effective in treating mixed infections, particularly those involving anaerobic bacteria and protozoa — often seen in gastrointestinal disorders, gynecological conditions, and post-operative infections.
This formulation is developed and manufactured by BluepillExpress, an internationally accredited third-party manufacturer and merchant exporter. The company’s robust production infrastructure ensures stringent adherence to international standards of quality, efficacy, and safety, with regulatory support for seamless global distribution.
Therapeutic Indications
Amoebic and bacterial dysentery
Giardiasis
Pelvic Inflammatory Disease (PID)
Bacterial vaginosis
Abdominal and post-surgical infections
Infective diarrhea and traveler’s diarrhea
Dental infections
Periodontal abscesses
Mixed infections of the gastrointestinal tract, reproductive organs, and respiratory system
Mechanism of Action
Ofloxacin: A fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV, leading to bacterial cell death.
Metronidazole: A nitroimidazole class antibiotic that gets activated in anaerobic conditions and disrupts DNA synthesis in protozoa and anaerobic bacteria.
Together, they deliver comprehensive antimicrobial action that is effective against both aerobic and anaerobic pathogens, as well as protozoal organisms.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
